Clinical Trials
3 trialsNCT07581002 2026-05-12
REVIVAL
AbbVie
Phase 2/3 Not yet recruiting
NCT07255872 2026-03-05
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3 Not yet recruiting
NCT07425808 2026-02-23
FIT-AML
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Not yet recruiting